ME/CFS Science @mecfsscience.org · 14/07/20261) A new randomized trial in Long Covid patients tested Temelimab, a drug that targets a potentially pathogenic protein (HERV-W ENV) from endogenous retroviruses. Unfortunately, the results are pretty clear: Temelimab had no beneficial effect. 3307
Ona Albizu - PhD MSc BD @onaalbizu.bsky.social · 15/07/2026I was at the first selection but I was negative to that protein so didn't get the drug. But I'm a responder to anti TNFalfa and IL17 monoclonals. I wonder why these two are not tested, viewing there are high values for a subgroup of pwME at several papers. 010
ME/CFS Science @mecfsscience.org · 14/07/20262) Endogenous retroviruses are virus remnants that we inherit and are already inside our genome. Almost all of them are broken and switched off. The hypothesis, however, is that a viral infection such as SARS-CoV-2 may reactivate some of their functions. 150
Post-Viral Trials @postviraltrials.bsky.social · 15/07/2026I believe this trial read out years ago, they just took a while to publish the full results 010
